Intravascular Large Cell non-Hodgkin Lymphoma in Subacute-Chronic Subdural Hematoma: a case report
DOI:
https://doi.org/10.33448/rsd-v11i13.32411Keywords:
Lymphoma; Intravascular; Subdural hematoma.Abstract
Introduction: Intravascular lymphoma (IVL) is a rare subtype of non-Hodgkin extranodal lymphoma with characterized by a positive CD20 B cell proliferation in small lumens and medium-sized blood vessels, except veins and large arteries. Blood vessels in the central nervous system (CNS) and the skin is most often affected. These tumors usually occur in older adults and aggressive. Methodology: Descriptive study of the case report type, whose data were obtained from the patient’s medical record and has received the patient's consent to be published. Case presentation: This paper reports a 63-year-old man, who suffered Parkinson disease and neurological symptoms for 6 months. From imaging, there is a chronic subacute subdural hematoma in the right frontotemporoparietal area. Operation performed, histopathological examination of the tissue with Hematoxylin-Eosin staining and immunohistochemical examination confirmed diagnosis Intravascular Large Cell non-Hodgkin Lymphoma (IVLCL) type B-cell CD20 (+) in subacute-chronic subdural hematoma (SDH). Discussion: This tumor is characterized by selective growth of lymphoma cells within the lumen of blood vessels, particularly capillaries, and with the exception of the larger arteries and veins, occurred in adults, with a median age of 67 years. Sixty five percent show neurological symptoms with rapidly progressive cognitive dysfunction or subacute dementia. The cause of chronic SDH in this patient is unknown, but it can occur due to increasing age, brain atrophy, and enlargement of the subdural space, relatively minor trauma. Conclusion: This lymphoma is aggressive with a poor prognosis but a chemotherapy regimen with rituximab significantly improves the clinical outcome of this patient, with an overall survival of 3 years 60-81%.
References
Alshora, W., Alfageeh, M., Alshahrani, S. et al. (2018). Diagnosis and management of subdural hematoma: a review of recent literature. International Journal Of Community Medicine And Public Health. 5(9), 3709-14
Arie, P. & Bradt, D. J. (2018). Lymphomas and Histiocytic Tumors. In: Leslie, K. O. & Wick, M. R. Practical Surgical Neuropathology. (2th ed.). p.410-11
Charifaa, A., Paulsona, N., Levyb, L., Perincheria, S., Leec, A., McNiffa, J. & Ko, C. (2020). Intravascular Large B-Cell Lymphoma: Clinical and Histopathologic Findings. Yale Journal Of Biology And Medicine, 93, 35-40
Chen R, Singh G, McNally J, et al. (2020). Intravascular Lymphoma with Progressive CNS Hemorrhage and Multiple Dissections. Case Reports in Neurological Medicine, 2020, p.1-7
Cheng S, Chang C, Chen S, et al. (2014). Chronic Subdural Hematoma in Elderly Taiwan Patients: A Retrospective Analysis of 342 Surgical Cases. International Journal of Gerontology, 8(1), p.37-41
Deckert M, Batchelor T, Ferry JA, et al. (2020). Intravascular Large B-cell Lymphoma. In Cree IA, Lokuhetty D, Peferoen LAN, White VA. WHO Classification of Tumours of Central Nervous System Tumor, 5th ed, p.360-61
Edlmann E, Giorgi-Coll S, Whitfield P, et al. (2017). Pathophysiology of chronic subdural haematoma: inflammation, angiogenesis and implications for pharmacotherapy. Journal of Neuroinflammation, 14 (1).
Fonkem E, Dayawansa S, Stroberg E, et al. (2016). Neurological presentations of intravascular lymphoma (IVL): meta-analysis of 654 patients. BMC Neurology, 16(1).
Lauw M, Lucas C, Ohgami R, & Wen K. (2020). Primary Central Nervous System Lymphomas: A Diagnostic Overview of Key Histomorphologic, Immunophenotypic, and Genetic Features. Diagnostics, 10 (12), 1076; doi:10.3390/diagnostics10121076
Liu Z, Zhang Y, Zhu Y, et al. (2020). Prognosis of Intravascular Large B cell Lymphoma (IVLBCL): Analysis of 182 patients from global case series, Cancer Management and Research 2020:12 p.10531–10540
Matsue K, Abe Y, Narita K, et al. (2019). Diagnosis of intravascular large B cell lymphoma: novel insights into clinicopathological features from 42 patients at a single institution over 20 years. British Journal of Haematology, 187(3), p.328-336
Miranda R, & Medeiros L. (2018). Diagnostic Pathology Lymph Node and Extranodal Lymphomas. (2th ed,). p.528-33
Nakamura S, Ponzoni M, & Campo E. (2017). Intravascular Large B-cell Lymphoma. In Swerdlow SH, Campo E, Hariss NL, Jaffe ES, Pileri SA, Stein H, Thiele J. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissue. Revised 4th ed. p317-18
Nizamutdinov D, Patel N, Huang J, et al. (2017). Intravascular Lymphoma in the CNS: Options for Treatment. Current Treatment Options in Neurology, 19(10).
Ong Y, Kao H, Chuang W, et al. (2021). Intravascular Large B-cell lymphoma: A case series and review of literatures. Biomedical Journal, 44 (4), p.479-488
Perry A, & Brat D. (2018). Practical surgical neuropathology. p.410
Shapey J, Glancz L, & Brennan P. (2016). Chronic Subdural Haematoma in the Elderly: Is It Time for a New Paradigm in Management? Current Geriatrics Reports, 5 (2), p.71–77 DOI 10.1007/s13670-016-0166-9
Uzuka T, Higuchi F, Matsuda H, Otani R, Kim P, & Ueki K. Intravascular Lymphoma with an Acute Course of Cerebellar Hemorrhage: A Case Report. Neurologia Medico Chirurgica (Tokyo) 58, February, 2018
Wu M, Lin Y, Huang X, et al. (2021). Intravascular large B-cell lymphoma presenting as rapidly progressive dementia and stroke: A case report. Medicine (United States), 100 (28).
Uno M, Toi H,& Hirai S. (2017). Chronic subdural hematoma in elderly patients: Is this disease benign? Neurologia Medico-Chirurgica, 57(8), p.402-09
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Herman Saputra ; Ni Putu Sriwidyani ; Putu Erika Paskarani ; Christine Rosalina Butar Butar
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
